CARLSBAD, Calif., April 22, 2025--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, and the Christopher & Dana ...

By integrating CRISPR-Cas9 induced gene editing with single cell RNA-Seq, high-resolution lineage tracing through molecular barcoding becomes feasible. However, tracking mutation evolution across ...

Whole genome landscape of small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; ...

My lab investigates how the genome dictates development using C. elegans as a model. Stunning movies captured in the lab of computational biologist Zhirong Bao reveal how cells divide, grow, and move ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

At close: April 17 at 4:00:00 PM EDT ...

1 Day LCTX -1.67% DJIA 0.05% Russell 2K 0.00% Health Care/Life Sciences -0.16% ...